ACR:Gaenslen’s实验阳性的RA患者疾病活动度高

2013-05-28 ACR dxy

Gaenslen's实验(GT)阳性是掌指关节(MCP)或跖趾关节(MTP)侧压疼痛的特征。来自奥地利维也纳医科大学的TANJA WIESINGER等人进行了一项研究,目的是评价GT阳性相关的因素和探讨GT阳性和GT阴性患者的疾病活动度差异。研究结果在线发布在2013年4月的《关节炎护理及研究》(Arthritis Care & Research)杂志上。作者发现,GT主要与MCP和MTP

Gaenslen's实验(GT)阳性是掌指关节(MCP)或跖趾关节(MTP)侧压疼痛的特征。来自奥地利维也纳医科大学的TANJA WIESINGER等人进行了一项研究,目的是评价GT阳性相关的因素和探讨GT阳性和GT阴性患者的疾病活动度差异。研究结果在线发布在2013年4月的《关节炎护理及研究》(Arthritis Care & Research)杂志上。作者发现,GT主要与MCP和MTP关节疼痛相关,能提示RA患者中到重度疾病活动。

GT是类风湿关节炎(RA)患者门诊就诊时的一项常规检查。研究共纳入229位GT阳性的患者(GT阳性组),并针对GT阳性组设置了GT阴性组(n=222)。两组在性别、年龄、病程、类风湿因子(RF)阳性等方面相匹配。研究者对疾病活动积分、肿胀关节数和疼痛关节数、患者自我整体评估、医生整体评估、晨僵、残疾评估,血清急性期反应物、RF和抗瓜氨酸蛋白抗体水平进行评估和回归分析,采用回归模型对GT阳性和GT阴性组进行比较。

研究结果如下,GT阳性组的所有的临床变量,包括疾病活动积分、肿痛关节数目和残疾评估均显著高于GT阴性组。而且,GT阳性组中仅有少数患者获得缓解和低疾病活动度。GT阳性与关节压痛(32或者28个关节计数)强相关(r>0.5)。近端指间关节、MCP和MTP疼痛似乎均可能出现GT阳性,但是一个以上的MCP/MTP疼痛能更好的解释GT阳性。

研究发现,GT主要与MCP和MTP关节疼痛相关,能提示RA患者中到重度的疾病活动。

Compression test (Gaenslen's squeeze test) positivity, joint tenderness, and disease activity in patients with rheumatoid arthritis.
OBJECTIVE
Gaenslen's test (GT) positivity is characterized by tenderness upon lateral compression (squeezing) of the metacarpophalangeal (MCP) or metatarsophalangeal (MTP) joints. We aimed to assess the factors related to a positive GT and to explore differences in disease activity between GT-positive and -negative patients.
METHODS
The GT was performed routinely in outpatients with rheumatoid arthritis (RA). In total, 229 patients had a positive GT (GT-positive group). To this group, we matched a GT-negative group (n = 222) comparable in sex, age, disease duration, and rheumatoid factor (RF) positivity. Disease activity scores, swollen and tender joint counts, patient pain and global assessments, evaluator's global assessment, morning stiffness, disability assessments, acute phase reactants, RF, and anti-citrullinated protein antibody levels were assessed and used for correlation analyses. A comparison between the GT-positive and -negative groups was performed and a regression model was calculated.
RESULTS
All clinical variables, including disease activity scores, joint counts, and disability assessments, were significantly higher in the GT-positive group than the GT-negative group. Also, there were significantly fewer patients in remission or with low disease activity in the GT-positive group. GT positivity correlated most strongly (r > 0.5) with joint tenderness (32- and 28-joint counts). Tender proximal interphalangeal, MCP, and MTP joints appeared mostly responsible for a positive GT, but more than 1 MCP/MTP joint had to be tender to explain a positive GT.
CONCLUSION
The GT is related primarily to tenderness in MCP and MTP joints and signifies a moderate to high disease activity among patients with RA.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1756025, encodeId=36601e560258b, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Thu Jan 09 21:38:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924384, encodeId=a677192438461, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu Jun 13 17:38:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799443, encodeId=35491e994438f, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Jun 11 00:38:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344881, encodeId=3f001344881a5, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400292, encodeId=f8b51400292ca, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1756025, encodeId=36601e560258b, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Thu Jan 09 21:38:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924384, encodeId=a677192438461, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu Jun 13 17:38:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799443, encodeId=35491e994438f, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Jun 11 00:38:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344881, encodeId=3f001344881a5, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400292, encodeId=f8b51400292ca, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1756025, encodeId=36601e560258b, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Thu Jan 09 21:38:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924384, encodeId=a677192438461, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu Jun 13 17:38:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799443, encodeId=35491e994438f, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Jun 11 00:38:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344881, encodeId=3f001344881a5, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400292, encodeId=f8b51400292ca, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1756025, encodeId=36601e560258b, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Thu Jan 09 21:38:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924384, encodeId=a677192438461, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu Jun 13 17:38:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799443, encodeId=35491e994438f, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Jun 11 00:38:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344881, encodeId=3f001344881a5, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400292, encodeId=f8b51400292ca, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1756025, encodeId=36601e560258b, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Thu Jan 09 21:38:00 CST 2014, time=2014-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924384, encodeId=a677192438461, content=<a href='/topic/show?id=34a8651660b' target=_blank style='color:#2F92EE;'>#活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65166, encryptionId=34a8651660b, topicName=活动度)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu Jun 13 17:38:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799443, encodeId=35491e994438f, content=<a href='/topic/show?id=7617e0693b6' target=_blank style='color:#2F92EE;'>#疾病活动度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70693, encryptionId=7617e0693b6, topicName=疾病活动度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Tue Jun 11 00:38:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344881, encodeId=3f001344881a5, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400292, encodeId=f8b51400292ca, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Thu May 30 04:38:00 CST 2013, time=2013-05-30, status=1, ipAttribution=)]
    2013-05-30 10518094zz

相关资讯

A&R:瓜氨酸化Hsp90α/β可能是RA相关肺间质病变的自身抗体标记物

部分类风湿关节炎(RA)患者可出现包括间质性肺炎(ILD)在内的关节外症状。由于目前尚缺乏评估RA患者合并发生ILD风险的方法,所以发现一种独特的RA-相关ILD(RA-ILD)血清标记物显得尤为重要。针对这一问题,来自美国迈阿密米勒医学院的Lisa Harlow等人进行了一项研究。研究结果发表于2013年4月的《关节炎与风湿病》(ARTHRITIS & RHEUMATISM)杂志上。研究

抗肿瘤坏死因子治疗或可增加带状疱疹发病风险

  一项英国风湿病学会生物制剂注册(BSRBR)研究显示,抗肿瘤坏死因子(TNF)治疗可显著升高类风湿关节炎(RA)患者带状疱疹的发病风险。论文发表于《风湿病年鉴》(Ann Rheum Dis 2013,72:229)杂志。   该研究共分析了11881例接受抗TNF治疗及3673例接受非生物性缓解病情抗风湿病药(nbDMARD)治疗患者,每6个月对患者及医师进行问

Ann Rheum Dis:抗肿瘤坏死因子治疗或可增加带状疱疹发病风险

一项英国风湿病学会生物制剂注册(BSRBR)研究显示,抗肿瘤坏死因子(TNF)治疗可显著升高类风湿关节炎(RA)患者带状疱疹的发病风险。论文发表于《风湿病年鉴》(Ann Rheum Dis 2013,72:229)杂志。  该研究共分析了11881例接受抗TNF治疗及3673例接受非生物性缓解病情抗风湿病药(nbDMARD)治疗患者,每6个月对患者及医师进行问卷调查随访。  结果,抗TNF组及nb

Arthritis Rheum:类风湿关节炎患者 THA后易脱臼,TKA后易感染

  加拿大一项研究显示,与骨性关节炎(OA)患者相比,类风湿关节炎(RA)患者行全髋关节置换术(THA)后发生脱臼和行全膝关节置换术(TKA)后感染风险较高。论文发表于《关节炎与风湿病》[Arthritis Rheum 2012,64(12):3839]杂志。   研究者检索Medline等数据库,选取1990~2011年间发表的RA、OA患者(≥200个关节)行TKA、TH

ARD:利妥昔单抗治疗可降低RA患者血清致动脉粥样硬化脂蛋白

致动脉粥样硬化血脂是心血管疾病(CV)的确定风险因素,而类风湿关节炎(CV)的高炎状态与不良血脂相关。新的免疫调节药物如利妥昔单抗(RTX)对血脂作用的数据有限。来自荷兰阿姆斯特丹UV大学医学中心的Hennie G Raterman等人对RTX治疗RA后患者血脂的变化进行了评估。研究结果发表在2013年4月的《风湿病学年鉴》(Ann Rheum Dis)杂志上。结果表明,RTX在改善疾病活动度的同

ACR:矩形风险模型预测RA患者快速放射学损害的效果不佳

应用于这一观察队列时,所有模型均表现出次最佳效能 矩形风险模型被建议用来作为类风湿关节炎(RA)患者快速放射学损害(RRP)预测的一种工具,但是,该模型应用于RA的经验有限。针对这一情况,来自美国波士顿马萨诸塞州布里格姆和妇女居屋医院和挪威奥斯陆Diakonhjemmet医院的SIRI LILLEGRAVEN等人进行了一项研究,该研究将3种风险模型应用于一个观察队列,分析风险模型的效能。研究结果